Trial updateCataract & IOL
Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery
Completed. Phase 2. Registered enrolment: 91. VivaVision Biotech, Inc
Why it matters
Track this study through NCT06164743. Results are available in the registry.
The study at a glance
- Registry status
- Completed
- Phase
- Phase 2
- Registered enrolment
- 91
- Results posted
- Yes
- Sponsor
- VivaVision Biotech, Inc
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.